BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 20333967)

  • 1. [Liver tumor as incidental ultrasound finding].
    Görtz RS; Strobel D
    MMW Fortschr Med; 2010 Jan; 152(3):41-3. PubMed ID: 20333967
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterisation of focal liver lesions with contrast enhanced ultrasonography.
    Dietrich CF
    Eur J Radiol; 2004 Jun; 51 Suppl():S9-17. PubMed ID: 15234021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver tumor characterization--comments and illustrations regarding guidelines.
    Dietrich CF
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S22-30. PubMed ID: 22723025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improved detection and characterisation of liver tumors with echo-enhanced ultrasound].
    Schuessler G; Ignee A; Hirche T; Dietrich CF
    Z Gastroenterol; 2003 Dec; 41(12):1167-76. PubMed ID: 14661127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
    Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver tumor characterization--review of the literature.
    Dietrich CF; Maddalena ME; Cui XW; Schreiber-Dietrich D; Ignee A
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S3-10. PubMed ID: 22723026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients].
    Bartolotta TV; Sandonato L; Taibbi A; Latteri S; Soresi M; Lombardo G; Genova C; Latteri MA
    Chir Ital; 2009; 61(3):295-307. PubMed ID: 19694231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of hepatocellular and cholangiocellular carcinoma, comments on the AASLD guidelines.
    Dietrich CF; Cui XW; Boozari B; Hocke M; Ignee A
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S57-66. PubMed ID: 22723030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of focal hepatic lesions with ultrasound contrast agents.
    Sutherland T; Temple F; Lee WK; Hennessy O
    J Clin Ultrasound; 2011 Sep; 39(7):399-407. PubMed ID: 21674510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
    Park YS; Lee CH; Kim JW; Shin S; Park CM
    World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.
    Sheybani A; Gaba RC; Lokken RP; Berggruen SM; Mar WA
    Curr Gastroenterol Rep; 2017 Oct; 19(11):58. PubMed ID: 29044439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of color Doppler sonography in primary liver tumors--a trend study.
    Weimann A; Repp H; Klempnauer J; Gebel M; Lang H; Ringe B; Pichlmayr R
    Bildgebung; 1993 Sep; 60(3):140-3. PubMed ID: 8251736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characterization of hepatic tumors with contrast-enhanced ultrasound and digital grey-scale analysis].
    Lemke AJ; Chopra SS; Hengst SA; Brinkmann MJ; Steinmüller T; Felix R
    Rofo; 2004 Nov; 176(11):1607-16. PubMed ID: 15497079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.
    Bertolotto M; Dalla Palma L; Quaia E; Locatelli M
    Eur Radiol; 2000; 10(9):1369-76. PubMed ID: 10997422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry.
    Heide R; Strobel D; Bernatik T; Goertz RS
    Ultraschall Med; 2010 Aug; 31(4):405-9. PubMed ID: 20652853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines.
    Barreiros AP; Piscaglia F; Dietrich CF
    J Hepatol; 2012 Oct; 57(4):930-2. PubMed ID: 22739095
    [No Abstract]   [Full Text] [Related]  

  • 17. Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound.
    Wang ZL; Tang J; Weskott HP; Li JL; Wang W; Luo YK; An LC; Xu JH
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1511-9. PubMed ID: 18713302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACG clinical guideline: the diagnosis and management of focal liver lesions.
    Marrero JA; Ahn J; Rajender Reddy K;
    Am J Gastroenterol; 2014 Sep; 109(9):1328-47; quiz 1348. PubMed ID: 25135008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-Enhanced Ultrasound of Focal Liver Lesions.
    D'Onofrio M; Crosara S; De Robertis R; Canestrini S; Mucelli RP
    AJR Am J Roentgenol; 2015 Jul; 205(1):W56-66. PubMed ID: 26102419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.